MedPath

Turgut Ardika PTY LTD

🇦🇺Australia
Ownership
Private
Established
2022-12-01
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

Comparative PK, Safety, Tolerability, Immunogenicity, and PD Profile Study of TUR03 and Soliris in Healthy Participants

Phase 1
Recruiting
Conditions
Healthy
Interventions
Drug: TUR03 300 MG in 30 ML Injection
First Posted Date
2023-05-18
Last Posted Date
2023-11-24
Lead Sponsor
Turgut Ardika PTY LTD
Target Recruit Count
120
Registration Number
NCT05863442
Locations
🇦🇺

Q-Pharm Pty Limited, Herston, Queensland, Australia

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.